MyBlueDotsOdyssey Therapeutics Appoints Jason Haas as Chief Financial Officer MyBlueDots5 months ago01 mins BOSTON–(BUSINESS WIRE)–Odyssey Therapeutics, Inc. today announced the appointment of Jason Haas, MBA, as chief financial officer (CFO). Post navigation Previous: GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 PatientsNext: Pet Honesty® Named Official Multivitamin Supplement of the American Kennel Club
‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target MyBlueDots2 days ago 0
New findings reveal how the heart is organized from the earliest stages of embryonic development MyBlueDots2 days ago 0
Scholastic performance is a key concern for young cancer patients, study finds MyBlueDots2 days ago 0